Patent ID: 9469877
Filing Date: 2016-10-18
CPC Classification: C12Q

Claim Text:
1. A set of detectably labeled probes for detecting pancreatobiliary cancer in a patient, wherein the set of detectably labeled probes consists of a locus-specific probe for MCL1 (myeloid cell leukemia sequence 1), which hybridizes to q21 on human chromosome 1, a locus-specific probe for EGFR (epidermal growth factor receptor), which hybridizes to p12 on human chromosome 7, a locus-specific probe for MYC, which hybridizes to q24 on human chromosome 8, and a locus-specific probe for P16, which hybridizes to p21 on human chromosome 9, and wherein each probe is detectably labeled with a distinct fluorophore.